Citius Oncology, Inc.
$0.78
-0.01 (-1.86%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +35.2%
- 3 Months
- -2.8%
- YTD
- -22.4%
- 1 Year
- -62.9%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 88.7%
- Largest decline max drawdown, since Aug 2025
- -77.3%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.68
Own CTOR?
See how CTOR contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.